SuperworthAlignment Healthcare profit margin ALHC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- 0.9%
- Operating margin, 12 months
- 1.2%
- Net margin on a year earlier
- +2.4 pts
- Peer median
- 4.1%
Over the twelve months to Jun 30, 2026, Alignment Healthcare kept 0.9% of its revenue as net profit, with an operating margin of 1.2%.
Five years earlier its net margin was −11.5%.
The median for 10 healthcare stocks of a similar size is 4.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin |
|---|---|---|
| FY2025 | −0.0% | 0.4% |
| FY2024 | −4.7% | −3.8% |
| FY2023 | −8.1% | −7.0% |
| FY2022 | −10.4% | −9.0% |
| FY2021 | −16.7% | −15.2% |
| FY2020 | −2.4% | −0.5% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 0.9% | +2.4 pts | 1.2% | |
| Q1 FY26 | 0.5% | +3.5 pts | 0.8% | |
| Q4 FY25 | −0.0% | +4.7 pts | 0.4% | |
| Q3 FY25 | −0.6% | +5.3 pts | 0.1% | |
| Q2 FY25 | −1.5% | +5.3 pts | −0.7% | |
| Q1 FY25 | −3.0% | +4.8 pts | −2.2% | |
| Q4 FY24 | −4.7% | +3.4 pts | −3.8% | |
| Q3 FY24 | −5.8% | +3.3 pts | −4.9% | |
| Q2 FY24 | −6.8% | +3.2 pts | −5.9% | |
| Q1 FY24 | −7.8% | +1.7 pts | −6.8% | |
| Q4 FY23 | −8.1% | +2.3 pts | −7.0% | |
| Q3 FY23 | −9.2% | +1.1 pts | −8.0% |
Against its peers
Companies in Healthcare nearest Alignment Healthcare's size, closest first, today.
| Company | Profit margin |
|---|---|
| ALHCAlignment Healthcare | 0.9% |
| ANIPANI Pharmaceuticals | 11.1% |
| ARDTArdent Health | 1.2% |
| HCSGHealthcare Services | 6.6% |
| PAHCPhibro Animal Health | 6.6% |
| EYENational Vision | 2.5% |
| CNMDCONMED | 4.1% |
| PNTGPennant | 2.9% |
| ANABAnaptysbio | n/m |
| PCRXPacira BioSciences | 2.0% |
| LMATLemaitre Vascular | 25.0% |
| Peer median | 4.1% |
Where Alignment Healthcare ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Alignment Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.